Bill Snyder

February 29, 2024

Study targets nicotine craving in schizophrenia

Vanderbilt’s Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.

By Bill Snyder
February 20, 2024

Vanessa Marlowe strives to create “caring connections” with patients and her colleagues

Marlowe recognized with VUMC Five Pillar Leader Award for her work

By Bill Snyder
February 19, 2024

VUMC part of major step to achieving precision medicine

An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.

By Bill Snyder
February 16, 2024

Vanderbilt to host international conference on endocrine surgery, March 14-16

By Bill Snyder
February 15, 2024

Katherine Hartmann, Sunil Kripalani honored at Translational Research Forum

Katherine Hartmann, MD, PhD, and Sunil Kripalani, MD, MSc, were honored for their service to translational scientists at Vanderbilt University Medical Center during the Vanderbilt Translational Research Forum.

By Bill Snyder
February 12, 2024

VISTA grant to fund hospital-based research training in heart, lung, blood, sleep disorders

Vanderbilt University Medical Center has received a federal grant to establish a first-of-its-kind training program in patient-oriented and health systems research focused on acute heart, lung, blood and sleep disorders in the hospital setting.

By Bill Snyder
February 7, 2024

Vanderbilt nanodrug may be a paradigm shift for cancer

A multidisciplinary research team at Vanderbilt University and Vanderbilt University Medical Center has discovered a new way to kill a tumor by disrupting its acidic “microenvironment” without harming normal tissue.
By Bill Snyder
February 7, 2024

VUMC study finds molecular switch key to repair of kidney damage

Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.
By Bill Snyder
February 1, 2024

A biomarker for early Type 2 diabetes

Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.
By Bill Snyder
January 30, 2024

3D brain mapping opens a window to the aging brain

By mapping brain activity in three dimensions, researchers at Vanderbilt University Medical Center have achieved a more detailed picture of how the brain changes with age.
By Bill Snyder
January 30, 2024

Four physician-scientists from VUMC receive national early-career awards

Four Vanderbilt physician-scientists have received awards from the American Society for Clinical Investigation.
By Bill Snyder
January 29, 2024

Nominations sought for the 2024 Vanderbilt Prize in Biomedical Science

Nominations for the 2024 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Feb. 29.
By Bill Snyder